We provide you with 20 years of free, institutional-grade data for RPTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RPTX. Explore the full financial landscape of RPTX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Repare Therapeutics Inc.(NASDAQ:RPTX) 
Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United States. It uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform, to discover, validat...
Website: https://www.reparerx.com
Founded: 2016
Full Time Employees: 180
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about RPTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.